Tag: TBI

Latest News

SanBio to Announce the Results of a Phase 2 STEMTRA Trial Regarding the Use of Regenerative Cell Medicine SB623 as a Treatment for TBI at an Annual Scientific Meeting of the American Association of Neurological Surgeons

MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–The SanBio Group (SanBio Co., Ltd. and SanBio, Inc.) (TOKYO: 4592), a scientific leader in regenerative medicine for neurological disorders, today announced...

Mild TBI May Fuel or Exacerbate Mental Health Problems

Mild TBI is associated with new onset or exacerbation of preexisting mental health problems in a substantial minority of patients, which has implications for follow-up...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy